Advarra Announces New Gene Therapy Ready Site Network
Advarra Announces New Gene Therapy Ready Site Network Research involving gene therapy-based treatments can start more quickly with this collective of pre-registered research sites News provided by Share this article Share this article COLUMBIA, Md., Jan. 19, 2021 /PRNewswire/ -- Advarra, the market leader in regulatory review solutions and clinical site technologies, announces the Gene Therapy Ready™ site network, a comprehensive collective of clinical research sites ready to conduct clinical trials involving genetically engineered vaccines, gene-modified cellular therapies, and gene thera...